ZS Pharma Al Guillem, chief executive of ZS Pharma, with Bill Sproull, chairman of the Texas Emerging Technology Fund state committee, when ZS Pharma received a grant from the Texas Emerging Technology Fund in Fort Worth in 2010.
ZS Pharma Al Guillem, chief executive of ZS Pharma, with Bill Sproull, chairman of the Texas Emerging Technology Fund state committee, when ZS Pharma received a grant from the Texas Emerging Technology Fund in Fort Worth in 2010. Rodger Mallison Star-Telegram/Rodger Mallison
ZS Pharma Al Guillem, chief executive of ZS Pharma, with Bill Sproull, chairman of the Texas Emerging Technology Fund state committee, when ZS Pharma received a grant from the Texas Emerging Technology Fund in Fort Worth in 2010. Rodger Mallison Star-Telegram/Rodger Mallison

AstraZeneca to buy Fort Worth startup ZS Pharma for $2.7 billion

November 06, 2015 09:36 AM